Priority Date: 20.01.11 (US 201161434776P)

HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR

  • Application ID: EP11725095
  • Status: The patent has been granted

Applicant

Technology company logo small
Technology Company

Attorney

Technology company logo thumb
no operation time available
Technology Company

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Genmab A/S is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 230 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 20.01.2011 - Priority Date (US 201161434776P)
  • 22.12.2011 - Publication A2 (WO2011157741)
  • 24.04.2013 - Publication A2 (EP2582728)
  • 23.08.2017 - Publication B1 (EP2582728)

IPC Classification